124 related articles for article (PubMed ID: 16350411)
1. Analysis of E7/Rb associations.
Caldeira S; Dong W; Tommasino M
Methods Mol Med; 2005; 119():363-79. PubMed ID: 16350411
[TBL] [Abstract][Full Text] [Related]
2. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
3. Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.
Alunni-Fabbroni M; Littlewood T; Deleu L; Caldeira S; Giarrè M; Dell' Orco M; Tommasino M
Oncogene; 2000 May; 19(19):2277-85. PubMed ID: 10822378
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
5. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.
Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A
Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916
[TBL] [Abstract][Full Text] [Related]
6. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
Hermonat PL; Santin AD; Zhan D
J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
[TBL] [Abstract][Full Text] [Related]
7. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
8. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein.
Zwerschke W; Joswig S; Jansen-Dürr P
Oncogene; 1996 Jan; 12(1):213-20. PubMed ID: 8552395
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.
Caldeira S; de Villiers EM; Tommasino M
Oncogene; 2000 Feb; 19(6):821-6. PubMed ID: 10698500
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle.
Mansour M; Touka M; Malena A; Indiveri C; Dong W; Gionfriddo I; Accardi R; Paradiso A; Sylla BS; Gabet AS; Tommasino M
Cancer Lett; 2007 Feb; 246(1-2):274-81. PubMed ID: 16650526
[TBL] [Abstract][Full Text] [Related]
11. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
12. Repression of p53 transcriptional activity by the HPV E7 proteins.
Massimi P; Banks L
Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
Avvakumov N; Torchia J; Mymryk JS
Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
[TBL] [Abstract][Full Text] [Related]
14. Expression and purification of His-tagged HPV16 E7 protein active in pRb binding.
Mirecka EA; Rudolph R; Hey T
Protein Expr Purif; 2006 Aug; 48(2):281-91. PubMed ID: 16814565
[TBL] [Abstract][Full Text] [Related]
15. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
Prathapam T; Kühne C; Banks L
Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
[TBL] [Abstract][Full Text] [Related]
16. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis.
Jones DL; Thompson DA; Münger K
Virology; 1997 Dec; 239(1):97-107. PubMed ID: 9426450
[TBL] [Abstract][Full Text] [Related]
17. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
18. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.
Massimi P; Pim D; Storey A; Banks L
Oncogene; 1996 Jun; 12(11):2325-30. PubMed ID: 8649772
[TBL] [Abstract][Full Text] [Related]
19. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
Ledl A; Schmidt D; Müller S
Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
[TBL] [Abstract][Full Text] [Related]
20. HPV18 E6 and E7 genes affect cell cycle, pRB and p53 of cervical tumor cells and represent prominent candidates for intervention by use peptide nucleic acids (PNAs).
Braun K; Ehemann V; Waldeck W; Pipkorn R; Corban-Wilhelm H; Jenne J; Gissmann L; Debus J
Cancer Lett; 2004 Jun; 209(1):37-49. PubMed ID: 15145519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
